Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹2,163 Cr₹1,911 Cr₹1,656 Cr₹1,245 Cr₹777 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹2,163 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹2,163 Cr
Mar2025₹1,911 Cr
Mar2024₹1,656 Cr
Mar2023₹1,245 Cr
Mar2022₹777 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹2,163 Cr
13.19
Mar2025 ₹1,911 Cr
15.39
Mar2024 ₹1,656 Cr
33.02
Mar2023 ₹1,245 Cr
60.22
Mar2022 ₹777 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹186,015.6 Cr -1.5% -1.6% 35.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹464,271.0 Cr -0.5% -0.3% 18.9% Stock Analytics
DIVIS LABORATORIES ₹226,843.0 Cr 3.1% 18.9% 33.2% Stock Analytics
CIPLA ₹118,072.0 Cr -0.9% 1.6% -2.5% Stock Analytics
MANKIND PHARMA ₹100,137.0 Cr -0.3% -4.2% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹100,073.0 Cr 2% -3.8% -0.7% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.5%

-1.6%

35.6%

SENSEX

-0.8%

0.5%

-3.8%


You may also like the below Video Courses